In 'Spontaneous' Liver Cancer, Georgetown University Researcher Sees a Cure
Adding more good news to last week’s announcement that Nexavar® (sorafenib) may be the first effective treatment for advanced liver cancer, researchers at the Lombardi Comprehensive Cancer Center at Georgetown University have uncovered a new molecular mechanism that may “spontaneously” cause liver cancer.